[144] Ginkgo Bioworks Holdings, Inc. SEC Filing

Rhea-AI Filing Summary

Ginkgo Bioworks (DNA) filed a Form 144 reporting proposed and recent insider sales of Class A common stock. The filer plans to sell 2,200 shares on or about 09/10/2025 through Fidelity Brokerage Services on the NYSE, with an aggregate market value listed as $23,716.00 and total outstanding Class A shares shown as 47,089,598. The filing discloses prior acquisitions by restricted stock vesting on 10/17/2022 (1,866 shares) and 10/18/2022 (334 shares) paid as compensation, and multiple recent sales during June–August 2025 totaling 4,995 shares with gross proceeds reported on individual dates. The filer certifies no undisclosed material adverse information.

Insights

Securities Analyst

TL;DR: Routine insider sale filing; modest volume relative to outstanding shares suggests limited immediate market impact.

The Form 144 documents proposed sale of 2,200 Class A shares and prior small transactions totaling 4,995 shares during June–August 2025. Given the issuer's reported 47,089,598 outstanding Class A shares, these transactions represent a de minimis percentage of float. The shares were largely acquired via restricted stock vesting in October 2022 and sold through standard brokerage channels. No new financial metrics, changes to operations, or material nonpublic disclosures are included, so the filing appears procedural under Rule 144.

Corporate Governance Expert

TL;DR: Disclosure meets Rule 144 requirements; signer affirms absence of undisclosed material information.

The filing provides the required transfer and sale details: acquisition dates, nature of acquisition (restricted stock vesting), sale dates, and gross proceeds. The representation that the seller lacks material nonpublic information is standard and important for compliance. There is no indication of a 10b5-1 plan adoption date or other trading-plan specifics disclosed. From a governance perspective, documentation is complete for a routine insider disposition.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Class A	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	2200	23716.00	47089598	09/10/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Class A	10/17/2022	Restricted Stock Vesting	Issuer			1866	10/17/2022	Compensation
Class A	10/18/2022	Restricted Stock Vesting	Issuer			334	10/18/2022	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Austin Che 27 Drydock Avenue 8th Floor Boston MA 02210	Class A	06/10/2025	99	791.01
Austin Che 27 Drydock Avenue 8th Floor Boston MA 02210	Class A	06/11/2025	99	884.07
Austin Che 27 Drydock Avenue 8th Floor Boston MA 02210	Class A	06/12/2025	99	941.49
Austin Che 27 Drydock Avenue 8th Floor Boston MA 02210	Class A	06/13/2025	99	883.08
Austin Che 27 Drydock Avenue, 8th Floor Boston MA 02210	Class A	06/16/2025	99	894.96
Austin Che 27 Drydock Avenue 8th Floor Boston MA 02210	Class A	06/17/2025	99	896.94
Austin Che 27 Drydock Avenue 8th Floor Boston MA 02210	Class A	06/18/2025	99	837.54
Austin Che 27 Drydock Avenue 8th Floor Boston MA 02210	Class A	06/20/2025	99	857.34
Austin Che 27 Drydock Avenue 8th Floor Boston MA 02210	Class A	06/23/2025	99	834.57
Austin Che 27 Drydock Avenue 8th Floor Boston MA 02210	Class A	07/09/2025	2200	24596.00
Austin Che 27 Drydock Avenue 8th Floor Boston MA 02210	Class A	08/06/2025	2200	31020.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)